Members of the House committee investigating the Jan. 6 attack listen during the fourth hearing on June 21, 2022, in Washington, D.C.
Mandel Ngan/POOL/AFP via Getty Images
Congress has the power to make sure government serves the public interest. Conducting investigations is one way lawmakers do that.
Changes to the Patented Medicine Prices Review Board regulations, which are intended to help lower drug costs in Canada, were originally scheduled to take effect in July 2020.
Changes to Canada’s Patented Medicine Prices Review Board regulations have been postponed for a fourth time in two years as Canadians continue to pay some of the highest drug prices in the world.
Prime Minister Justin Trudeau during his victory speech on election night, Sept. 21, 2021.
THE CANADIAN PRESS/Paul Chiasson
Canada’s lack of pharmacare harms health in our communities, strains our health-care system and encumbers our economy. Parliament is out of excuses for not implementing a national drug plan.
For people with disabilities, prescription drug costs are often layered on top of other health-related costs.
Any pharmacare plan that aims to remove financial barriers to treatment and eliminate inequities should prioritize those who face the highest out-of-pocket drug costs, such as people with disabilities.
Indian health workers doing health checks in Mumbai, June 17, 2020.
AP Photo/Rafiq Maqbool, File
The high cost of pharmaceuticals often means only the richest patients get lifesaving medicines. As coronavirus drugs emerge, it will require hard, creative work to ensure they’re available to all.
Prescription drugs in the U.S. are so costly, some people skip their medications.
Getty Images / Shana Novak
Studies repeatedly have shown that health care in general and the high cost of drugs in particular are among the top concerns of US voters. But with coronavirus, the issue may fade from prominence.
Policymakers and consumers are well aware of rising pharmaceuticals prices.
AP Photo/Elise Amendola
The Trump administration’s proposal to lower drug prices focuses on discounts. A health policy scholar argues that the US could learn from Europe’s system of measuring drug value and effectiveness.
Supply and demand are often out of sync in the drug industry.
Shortages and high prices are making pharmaceuticals, often including generics, out of reach for millions of Americans.
Heather Bresch, CEO of Mylan, holds two EpiPens as she testified before Congress Sept. 21, 2016 about rising costs of the drug.
AP Photo/Pablo Martinez Monsivais
The rising costs of generic drugs have led to outcries. In a search for solutions, four hospital systems are proposing to make drugs on their own. Could their idea work?